en
Scientific article
Open access
English

Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine

Published inCancer Research, vol. 61, no. 21, p. 7971-7977
Publication date2001
Abstract

Use of radiolabeled nucleotides for tumor imaging is hampered by rapid in vivo degradation and low DNA-incorporation rates. We evaluated whether blocking of thymidine (dThd) synthesis by 5-fluoro-2'-deoxyuridine (FdUrd) could improve scintigraphy with radio-dThd analogues, such as 5-iodo-2'-deoxyuridine (IdUrd). We first show in vitro that coincubation with FdUrd substantially increased incorporation of [125I]IdUrd and [3H]dThd in the three tested human glioblastoma lines. Flow cytometry analysis showed that a short coincubation with FdUrd (1 h) produces a signal increase per labeled cell. We then measured biodistribution 24 h after i.v. injection of [125I]IdUrd in nude mice s.c. xenografted with the three glioblastoma lines. Compared with animals given [125I]IdUrd alone, i.v. preadministration for 1 h of 10 mg/kg FdUrd increased the uptake of [125I]IdUrd in the three tumors 4.8-6.8-fold. Compatible with previous reports, there were no side effects in mice observed for 2 months after receiving such a treatment. The tumor uptake of [125I]IdUrd was increased < or =13.6-fold when FdUrd preadministration was stepwise reduced to 1.1 mg/kg. Uptake increases remained lower (between 1.7- and 5.8-fold) in normal proliferating tissues (i.e., bone marrow, spleen, and intestine) and negligible in quiescent tissues. DNA extraction showed that 72-80% of radioactivity in tumor and intestine was bound to DNA. Scintigraphy of xenografted mice was performed at different times after i.v. injection of 3.7 MBq [125I]IdUrd. Tumor detection was significantly improved after FdUrd preadministration while still equivocal after 24 h in mice given [125I]IdUrd alone. Furthermore, background activity could be greatly reduced by p.o. administration of KClO4 in addition to potassium iodide. We conclude that FdUrd preadministration may improve positron or single photon emission tomography with cell division tracers, such as radio-IdUrd and possibly other dThd analogues.

Keywords
  • Animals
  • Brain Neoplasms/diagnostic imaging/metabolism/pathology
  • Cell Cycle/drug effects
  • DNA, Neoplasm/metabolism
  • Drug Synergism
  • Floxuridine/pharmacology/toxicity
  • Glioblastoma/diagnostic imaging/metabolism/pathology
  • Humans
  • Idoxuridine/pharmacokinetics/toxicity
  • Iodine Radioisotopes
  • Male
  • Mice
  • Mice, Nude
  • Perchlorates/pharmacology
  • Potassium Compounds/pharmacology
  • Radionuclide Imaging/methods
  • Radiopharmaceuticals/pharmacokinetics/toxicity
  • Thymidine/metabolism
  • Tissue Distribution
  • Tritium
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays
Funding
  • Swiss National Science Foundation - 31-47 204.96
Citation (ISO format)
DUPERTUIS, Yves Marc et al. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine. In: Cancer Research, 2001, vol. 61, n° 21, p. 7971–7977.
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal0008-5472
111views
25downloads

Technical informations

Creation03/04/2021 2:11:00 PM
First validation03/04/2021 2:11:00 PM
Update time03/16/2023 12:14:28 AM
Status update03/16/2023 12:14:27 AM
Last indexation01/17/2024 12:44:22 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack